東陽光藥(01558.HK):選舉第三屆董事會董事及監事會監事
格隆匯6月4日丨東陽光藥(01558.HK)公佈,經股東周年大會的批准,蔣均才、王丹津、陳燕桂及李爽被重新選舉為第三屆董事會執行董事,唐新發及黃翊先被重新選舉為第三屆董事會非執行董事以及唐建新、趙大堯先生、向凌及李學臣被重新選舉為第三屆董事會獨立非執行董事。此外,公司選舉唐新發作為第三屆董事會董事長。
經股東周年大會的批准,唐金龍及羅忠華被重新選舉為第三屆監事會的股東代表監事,連同已於2021年3月10日獲選舉為職工代表監事的王勝超組成公司第三屆監事會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.